Safeguard Scientifics exits Lumesis via sale to SOLVE Advisors for $5.3M initial cash

SAFEGUARD SCIENTIFICS INC

Safeguard received $5.3M initial cash proceeds from sale of Lumesis stake to SOLVE Advisors.
Additional cash may come from final net working capital adjustments and escrow contingencies.
Safeguard deployed $5.6M to Lumesis since 2012; expects to report a gain in Q3 2022.
CEO Eric Salzman highlighted progress on portfolio monetization for shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.